We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Medlab Middle East Sees 100% Increase in Exhibitor Numbers

By LabMedica International staff writers
Posted on 16 Jan 2023
Print article
The focus on technology and sustainability has seen unprecedented demand from exhibitors (Photo courtesy of Informa Markets)
The focus on technology and sustainability has seen unprecedented demand from exhibitors (Photo courtesy of Informa Markets)

Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, has sold out its exhibitor space ahead of the show, which returns to the Dubai World Trade Centre from February 6 to 9, 2023.

The latest statistics from the Medlab Middle East organizer, Informa Markets (London, UK), reveal that the number of exhibition halls is up from four to six, with a total of 31,000 sq. mt. of space. Over 350 new exhibitors have been confirmed, taking the total to more than 700, with 180 countries represented, marking a 100% increase as compared to the 2022 edition of the show. Additionally, international pavilions have also increased from 11 to 14.

In line with the Medlab Middle East theme, ‘paving the way for technological advancements and sustainability in laboratory medicine’, various exhibitors will showcase their latest products in fields such as disposables, imaging, IT systems, and medical equipment, among others, contributing to the rise in exhibitor numbers. Apart from a full line-up of exhibitors on the show floor, Medlab Middle East will launch its Hosted Buyer program, which will match exhibitors with senior decision-makers belonging to the healthcare industry. The show floor will also offer a series of seminars and workshops to allow visitors to learn first-hand about the latest medical laboratory innovations from the exhibitors.

At Medlab Middle East, the newly-launched Labpreneur competition will invite promising diagnostic start-up companies to pitch groundbreaking ideas that can transform the laboratory market to a panel of experts who will select the winner on the final day of the exhibition. This year, the Medlab Middle East Congress will also return, providing education and solutions to advance laboratory skills and improve laboratory functions to over 5,000 conference delegates. With 12 conferences, the Congress is the largest CME-accredited multi-track medical laboratory congress in the world, featuring 130+ local and international speakers. This year's conference program will include eight core lab conference tracks, with further four new additions addressing Point of Care Testing (POCT), Tech Advances and Clinical Impact, New trends in laboratory medicine, Quality Management in the Lab, and Sustainability in the Lab. For the first time, Medlab Middle East will showcase a new Entertainment zone – The Village, which will provide a more relaxed environment to the attendees for networking.

“It has been an incredible year of growth for the medical laboratory industry and Medlab Middle East. This year we will welcome 650 exhibitors from 180 countries, many of whom are making their debut at the event by highlighting the latest technological advances on the market,” said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “We are also welcoming back several of our Asian counterparts who have been unable to travel due to restrictions in their home countries as well as stalwarts of the event Abbott, Biomerieux, Beckman Coulter, Randox, illumina, bioMérieux, Randox and Mindray, amongst others.”


Gold Supplier
Zika Virus Anitobody Test
Zika Virus IgM μ-capture
Gold Supplier
Cerebral Spinal Fluid Control
Multichem CSF
PCR Automatic Hybridization System
HybriSpot 12 Auto
Carcinoembryonic Antigen Rapid Test
CEA Rapid Test Kit

Print article


Clinical Chem.

view channel
Image: By analyzing urine of patients, it is possible to determine their likelihood of death (Photo courtesy of University of Liverpool)

Urine Test Accurately Predicts End of Life for Lung Cancer Patients

Lung cancer continues to be the leading cause of cancer-related deaths for both men and women around the globe. This deadly disease can affect its victims in various ways, such as through tumor growth... Read more

Molecular Diagnostics

view channel
Image: Biomarkers have shown promise for identifying early risk of pancreatic cancer (Photo courtesy of Pexels)

Biomarker-Based Approach Could Identify Early Risk of Pancreatic Cancer

The incidence of pancreatic cancer is increasing, although the cause of its growing prevalence remains unknown. Even if pancreatic cancer is detected in its early stages, it usually spreads cells throughout... Read more


view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more


view channel
Image: Sampling a single stool using multiple PCR panels can identify more pathogens rapidly (Photo courtesy of Pexels)

PCR Panels for Acute GI Infections Can Lower Costs, Hospitalization and Antibiotic Use

Acute gastroenteritis impacts adults across all age groups and incurs enormous healthcare expenses. Now, a new study comprising 40,000 hospital visits across various geographic locations has revealed that... Read more


view channel
Image: QAi Prostate is an advanced AI-powered prostate cancer diagnosis tool for pathologists (Photo courtesy of Qritive)

AI-Powered Prostate Cancer Diagnosis Tool Accurately Identifies and Classifies Tumors

Prostate adenocarcinoma is the most prevalent form of prostate cancer, representing around 90% of all prostate cases, and is also the second most commonly occurring cancer in men, demonstrating a steady... Read more


view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.